Eric Buffkin is a repeat entrepreneur and executive with more than 25 years of experience launching tech and health-tech ventures. As of August 2021, Eric takes the helm as the new CEO and President of etectRx. He plans to build on the company’s current momentum and continue to build the importance of the etectRx digital pill system to the healthcare market.

As a co-founder of the company, he has a long-standing commitment to etectRx company values, digital pill technology and the market potential for the ID-Cap™ System. Eric continues to set the direction for etectRx technology, creating meaningful conversations with target collaborators on improving health data and creating unequivocal medication ingestion records.

Eric was previously the Senior Vice President of Development and Technical Operations for etectRx and led the team to FDA clearance for the ID-Cap System in December 2019. Outside of etectRx, Eric founded the Pelagic Group, an active consulting firm focused on advising STEM startups. He is also currently a mentor at the University of Florida and Carnegie Melon, providing advice and counsel in innovation and entrepreneurship accelerator programs. Eric has served in executive roles with Intellon Corporation and Motorola earlier in his career.

Eric has a Master of Business Administration from Rollins College and a Bachelor of Science in Electrical Engineering from the University of Florida. He holds three active US and International patents and multiple pending patients.